Obamacare is Unhealthy for Medical Devices ETFs
November 14th, 2012 at 9:34am by Tom Lydon
The health care sector benefits from President Barack Obama’s second term win, as rival Mitt Romney wanted to repeal Obamacare if elected, but the Affordable Health Care Act will take a toll on the medical devices exchange traded fund sub-sector, due to taxes.
According to a Battelle Technology Partnerships Practice study, Obamacare includes a “stealth” tax on medical device makers, writes the ETF Professor for Benzinga. Battelle projected that the health care act would lead to tens of thousands of cut jobs and billions of dollar lost GDP for the U.S. [Election Could Make or Break Health Care ETFs]
Medical devices ETFs, like the iShares Dow Jones US Medical Devices Index Fund (NYSEArca: IHI) and SPDR S&P Health Care Equipment ETF (NYSEArca: XHE), would mirror the blow on the sub-sector, which include prominent names like Medtronic (NYSE: MDT), Intuitive Surgical (NasdaqGM: ISRG) and St. Jude Medical (NYSE: STJ).
According to the Washington Times, a number of medical equipment providers have already considered per-emptive layoffs in anticipation of the Medical Device Tax. For example, Medtronic has cut 500 jobs over the summer and will reduce a further 500 jobs by the end of 2013. St. Jude Medical also plans 300 layoffs.
Broad health care ETFs that include the major blue-chip pharmaceutical companies, like Johnson & Johnson (NYSE: JNJ), Pfizer (NYSE: PFE) and Merck (NYSE: MRK), also hold a portion in medical devices.
For instance, the Dow Jones U.S. Healthcare Sector Index Fund (NYSEArca: IYH) allocates 33.6% to health care equipment & services and the Health Care Select Sector SPDR Fund (NYSEArca: XLV) has 14.9% in health care equipment & supplies.
iShares Dow Jones US Medical Devices Index Fund
For more information on the health care industry, visit our health care category.
Max Chen contributed to this article.
The opinions and forecasts expressed herein are solely those of Tom Lydon, and may not actually come to pass. Information on this site should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any product.